1-225921199-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_013328.4(PYCR2):c.797+9A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.1 in 1,609,918 control chromosomes in the GnomAD database, including 9,014 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.080 ( 637 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8377 hom. )
Consequence
PYCR2
NM_013328.4 intron
NM_013328.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.07
Genes affected
PYCR2 (HGNC:30262): (pyrroline-5-carboxylate reductase 2) This gene belongs to the pyrroline-5-carboxylate reductase family. The encoded mitochondrial protein catalyzes the conversion of pyrroline-5-carboxylate to proline, which is the last step in proline biosynthesis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Nov 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-225921199-T-G is Benign according to our data. Variant chr1-225921199-T-G is described in ClinVar as [Benign]. Clinvar id is 1167877.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PYCR2 | NM_013328.4 | c.797+9A>C | intron_variant | Intron 6 of 6 | ENST00000343818.11 | NP_037460.2 | ||
PYCR2 | NM_001271681.2 | c.575+9A>C | intron_variant | Intron 5 of 5 | NP_001258610.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0806 AC: 12252AN: 152090Hom.: 637 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12252
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.100 AC: 24801AN: 247846 AF XY: 0.107 show subpopulations
GnomAD2 exomes
AF:
AC:
24801
AN:
247846
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.102 AC: 149366AN: 1457710Hom.: 8377 Cov.: 32 AF XY: 0.105 AC XY: 76380AN XY: 725048 show subpopulations
GnomAD4 exome
AF:
AC:
149366
AN:
1457710
Hom.:
Cov.:
32
AF XY:
AC XY:
76380
AN XY:
725048
show subpopulations
African (AFR)
AF:
AC:
495
AN:
33394
American (AMR)
AF:
AC:
2182
AN:
44318
Ashkenazi Jewish (ASJ)
AF:
AC:
3872
AN:
25826
East Asian (EAS)
AF:
AC:
2249
AN:
39658
South Asian (SAS)
AF:
AC:
12950
AN:
85814
European-Finnish (FIN)
AF:
AC:
6873
AN:
53310
Middle Eastern (MID)
AF:
AC:
713
AN:
5722
European-Non Finnish (NFE)
AF:
AC:
113995
AN:
1109466
Other (OTH)
AF:
AC:
6037
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
6292
12585
18877
25170
31462
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0805 AC: 12251AN: 152208Hom.: 637 Cov.: 32 AF XY: 0.0821 AC XY: 6107AN XY: 74428 show subpopulations
GnomAD4 genome
AF:
AC:
12251
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
6107
AN XY:
74428
show subpopulations
African (AFR)
AF:
AC:
796
AN:
41562
American (AMR)
AF:
AC:
1091
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
545
AN:
3470
East Asian (EAS)
AF:
AC:
309
AN:
5168
South Asian (SAS)
AF:
AC:
675
AN:
4818
European-Finnish (FIN)
AF:
AC:
1358
AN:
10594
Middle Eastern (MID)
AF:
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7226
AN:
67982
Other (OTH)
AF:
AC:
182
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
585
1169
1754
2338
2923
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
307
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Mar 18, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hypomyelinating leukodystrophy 10 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.